SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities

JAMA. 2021 Mar 16;325(11):1037-1038. doi: 10.1001/jama.2021.2294.
No abstract available

MeSH terms

  • COVID-19 / virology*
  • COVID-19 Vaccines*
  • Humans
  • SARS-CoV-2 / genetics*
  • United States

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants